Cargando…
Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation
Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409933/ https://www.ncbi.nlm.nih.gov/pubmed/36013374 http://dx.doi.org/10.3390/life12081195 |
_version_ | 1784774971635007488 |
---|---|
author | Radakovic, Dejan Penov, Kiril Hamouda, Khaled Madrahimov, Nodir Radakovic, Darko Bening, Constanze Leyh, Rainer G. Aleksic, Ivan |
author_facet | Radakovic, Dejan Penov, Kiril Hamouda, Khaled Madrahimov, Nodir Radakovic, Darko Bening, Constanze Leyh, Rainer G. Aleksic, Ivan |
author_sort | Radakovic, Dejan |
collection | PubMed |
description | Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 patients treated with either VA-ECMO only or in combination with IABP (ECMO-I group) between January 2012 and January 2021. To adjust the patients’ backgrounds, we used propensity score matching for additional analyses, resulting in 57 pairs. The primary endpoint was 30-day survival. Secondary endpoints included successful weaning and complication rates. We also analysed hemodynamic parameters in both groups. Results: After propensity score matching, 30-day survival was better in the ECMO-I group (log-rank p = 0.004). The ECMO-I and ECMO-only groups differed regarding the secondary endpoints, including successful weaning (50.9% and 26.3%, respectively; p = 0.012) and the need for continuous renal replacement therapy (28.1% and 50.9%, p = 0.021). Complication rates were not statistically different between the two groups. Conclusion: Compared to VA-ECMO alone, the combined use of VA-ECMO and IABP is beneficial regarding 30-day survival in selected patients with postcardiotomy shock; successful ECMO weaning and freedom from renal replacement therapy is more common in patients supported with VA-ECMO plus IABP. |
format | Online Article Text |
id | pubmed-9409933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94099332022-08-26 Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation Radakovic, Dejan Penov, Kiril Hamouda, Khaled Madrahimov, Nodir Radakovic, Darko Bening, Constanze Leyh, Rainer G. Aleksic, Ivan Life (Basel) Article Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 patients treated with either VA-ECMO only or in combination with IABP (ECMO-I group) between January 2012 and January 2021. To adjust the patients’ backgrounds, we used propensity score matching for additional analyses, resulting in 57 pairs. The primary endpoint was 30-day survival. Secondary endpoints included successful weaning and complication rates. We also analysed hemodynamic parameters in both groups. Results: After propensity score matching, 30-day survival was better in the ECMO-I group (log-rank p = 0.004). The ECMO-I and ECMO-only groups differed regarding the secondary endpoints, including successful weaning (50.9% and 26.3%, respectively; p = 0.012) and the need for continuous renal replacement therapy (28.1% and 50.9%, p = 0.021). Complication rates were not statistically different between the two groups. Conclusion: Compared to VA-ECMO alone, the combined use of VA-ECMO and IABP is beneficial regarding 30-day survival in selected patients with postcardiotomy shock; successful ECMO weaning and freedom from renal replacement therapy is more common in patients supported with VA-ECMO plus IABP. MDPI 2022-08-05 /pmc/articles/PMC9409933/ /pubmed/36013374 http://dx.doi.org/10.3390/life12081195 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Radakovic, Dejan Penov, Kiril Hamouda, Khaled Madrahimov, Nodir Radakovic, Darko Bening, Constanze Leyh, Rainer G. Aleksic, Ivan Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title | Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title_full | Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title_fullStr | Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title_full_unstemmed | Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title_short | Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation |
title_sort | benefits of intra-aortic balloon pump support in patients with postcardiotomy shock requiring venoarterial extracorporeal membrane oxygenation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409933/ https://www.ncbi.nlm.nih.gov/pubmed/36013374 http://dx.doi.org/10.3390/life12081195 |
work_keys_str_mv | AT radakovicdejan benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT penovkiril benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT hamoudakhaled benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT madrahimovnodir benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT radakovicdarko benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT beningconstanze benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT leyhrainerg benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation AT aleksicivan benefitsofintraaorticballoonpumpsupportinpatientswithpostcardiotomyshockrequiringvenoarterialextracorporealmembraneoxygenation |